Technavio expects global immunoprotein diagnostic testing market to reach over $11 billion by 2019

Renewable energy

 

This market study presents a detailed analysis and segmentation of the global immunoprotein diagnostic testing market by application (infectious disease testing, oncology and endocrine testing, autoimmune testing, and allergy testing) and by geography (APAC, EMEA, and the Americas). Key vendors analyzed in this market study are Beckman Coulter, Diasorin, Roche Diagnostics, Siemens Healthcare, and Thermo Fisher Scientific.

Technavio has released its new market research report, global immunoprotein diagnostic testing market, which is expected to grow at a CAGR of 7% between 2015 and 2019. The market for immunoprotein diagnostic testing is positively influenced by factors like the growing elderly population and the increased incidence and prevalence of chronic diseases. The Americas dominate the global market for immunoprotein diagnostic testing, occupying 45% of the total market share. Much of this region’s growth can be attributed to factors like the rise in laboratory automation, shift to POC rapid diagnostic tests, and increased FDA approval for new products. The US is considered to be the largest revenue contributor due to the high prevalence of chronic and infectious diseases in this region.

Of late, the vendors are increasingly using multiplex bead-based assays in diagnostic testing. In this method, the polystyrene beads are labeled with precise amounts of a single fluorophore of discrete fluorescence intensities to help separate components by using a flow cytometer. Multiplex bead-based assay readers allow analysis of 100 reactions or assays per well. For instance, FlowCytomix Multiple Analyte Detection System detects 20 analytes in one sample using a flow cytometer,” says Brahadeesh Chandrasekaran, Lead Analyst, Healthcare & Lifesciences, Technavio Research

Growing focus on early disease diagnosis is the key driver for the growth of this market. Early diagnosis by immunoprotein diagnostic devices helps in disease screening and patient care management during a disease outbreak. Advantages like its ability to reduce the total healthcare expenditure and its ability to reduce the recovery time of patients are expected to impel market growth during the forecast period.

The leading vendors in the global immunoprotein diagnostic testing market include Beckman Coulter, Diasorin, Roche Diagnostics, Siemens Healthcare, and Thermo Fisher Scientific. This market is characterized by the presence of intense competition between numerous large, medium, and small-sized manufacturers that provide different type of immunoprotein diagnostic products based on technologies like ELISA, RIA, and CLIA. These vendors form partnerships and provide premium-priced products to laboratories and patients so as to establish themselves in the market.

A more detailed analysis is available in the Technavio report, Global Immunoprotein Diagnostic Testing Market 2015-2019.

We can customize this reports by other regions and specific segments upon request.

Other related reports:

Further readings: